You plan to file a patent application for an invention that uses and/or claims a biological material. Do you need to deposit a sample of the biological material with a recognized depository institution? This article explores the strategic considerations for biological deposits to satisfy the regulations of patent offices in the United States and Europe.
Recent Posts
- Latest Trump Executive Order Redirects Drug Pricing Debate
- Lutnick Tells Inventors, ‘You Have a Friend’ at Commerce
- Other Barks & Bites for Friday, May 9: USPTO Responds to GAO Report; Stewart Welcomes National Inventors Hall of Fame Inductees; CAFC Defines ‘Ground’ for IPR Estoppel Statute
- PTAB Designates as Informative Stewart Decision on Discretion to Institute in Context of Parallel District Court Litigation
- Judge Hughes Again Calls Out CAFC’s Overly Rigid Article III Analysis for Pharmaceutical Cases